Pharmaceutical Business review

Lonza to expand Singapore manufacturing plant

The expansion will add 1858m² of space and associated equipment and support cell line construction, upstream and downstream process development, and a range of analytical services.

The expanded facility expects to offer customers a range of services from development through pre-clinical and small-scale manufacturing, to large-scale commercial supply.

Lonza Development Services head Janet White said they are looking forward to offering the full range of GS Gene Expression System and other technologies in Asia.